{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:53:53Z","timestamp":1788144833000,"version":"build-2803163510"},"reference-count":25,"publisher":"BMJ","issue":"7","funder":[{"name":"Perinatal Ireland, HRB"},{"name":"HRB Mother and Baby Clinical Trials Network"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,6,22]]},"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Evaluate the feasibility and acceptability of routine aspirin in low-risk women, compared with screening-test indicated aspirin for the prevention of pre-eclampsia and fetal growth restriction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre open-label feasibility randomised controlled trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Two tertiary maternity hospitals in Dublin, Ireland.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>546 low-risk nulliparous women completed the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Women underwent computerised randomisation to: Group 1\u2014routine aspirin 75\u2009mg from 11 until 36 weeks; Group 2\u2014no aspirin and; Group 3\u2014aspirin based on the Fetal Medicine Foundation screening test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>(1) Proportion agreeing to participate; (2) compliance with protocol; (3) proportion where first trimester uterine artery Doppler was obtainable and; (4) time taken to issue a screening result. Secondary outcomes included rates of pre-eclampsia and small-for-gestational-age fetuses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>546 were included in the routine aspirin (n=179), no aspirin (n=183) and screen and treat (n=184) groups. 546 of 1054 were approached (51.8%) and enrolled. Average aspirin adherence was 90%. The uterine artery Doppler was obtained in 98.4% (181\/184) and the average time to obtain a screening result was 7.6 (0\u201326) days. Of those taking aspirin, vaginal spotting was greater; n=29 (15.1%), non-aspirin n=28 (7.9%), OR 2.1 (95% CI 1.2 to 3.6). Postpartum haemorrhage &gt;500\u2009mL was also greater; aspirin n=26 (13.5%), no aspirin n=20 (5.6%), OR 2.6 (95% CI 1.4 to 4.8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Low-risk nulliparous women are open to taking aspirin in pregnancy and had high levels of adherence. Aspirin use was associated with greater rates of vaginal bleeding. An appropriately powered randomised controlled trial is now required to address the efficacy and safety of universal low-dose aspirin in low-risk pregnancy compared with a screening approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ISRCTN (15191778); Post-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-022056","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T05:15:59Z","timestamp":1532754959000},"page":"e022056","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["<i>T<\/i>\n                    rial of feasibility and acceptability of routine low-dose aspirin versus\n                    <i>E<\/i>\n                    arly\n                    <i>S<\/i>\n                    creening\n                    <i>T<\/i>\n                    est indicated aspirin for pre-eclampsia prevention (\n                    <i>TEST<\/i>\n                    study): a multicentre randomised controlled trial"],"prefix":"10.1136","volume":"8","author":[{"given":"Fionnuala","family":"Mone","sequence":"first","affiliation":[{"name":"UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mulcahy","sequence":"additional","affiliation":[{"name":"UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"McParland","sequence":"additional","affiliation":[{"name":"UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"Breathnach","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Downey","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"McCormack","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Culliton","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Stanton","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cody","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Morrison","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, National University of Ireland, Galway, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Daly","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Coombe Women\u2019s and Infant\u2019s University Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University College Cork, Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Cotter","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Graduate Entry Medical School, University of Limerick, Limerick, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Hunter","sequence":"additional","affiliation":[{"name":"Royal Jubilee Maternity Hospital, Belfast, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C","family":"Tully","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dicker","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zarko","family":"Alfirevic","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergal D","family":"Malone","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Rotunda Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala M","family":"McAuliffe","sequence":"additional","affiliation":[{"name":"UCD Perinatal Research Centre, School of Medicine, University College Dublin, National Maternity Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"key":"2025120601051168000_8.7.e022056.1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2844"},{"key":"2025120601051168000_8.7.e022056.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310213291701"},{"key":"2025120601051168000_8.7.e022056.3","doi-asserted-by":"publisher","DOI":"10.1159\/000341264"},{"key":"2025120601051168000_8.7.e022056.4","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2016.09.086","article-title":"Should we recommend universal aspirin for all pregnant\u00a0women?","volume":"216","author":"Mone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2025120601051168000_8.7.e022056.5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025120601051168000_8.7.e022056.6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2025120601051168000_8.7.e022056.7","doi-asserted-by":"crossref","first-page":"iii-iv, 1-270","DOI":"10.3310\/hta12060","article-title":"Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling","volume":"12","author":"Meads","year":"2008","journal-title":"Health Technol Assess"},{"key":"2025120601051168000_8.7.e022056.8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2016.07.003","article-title":"An open-label randomized-controlled trial of low dose aspirin with an early screening test for pre-eclampsia and growth restriction (TEST): trial protocol","volume":"49","author":"Mone","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"2025120601051168000_8.7.e022056.9","unstructured":"NICE. Guideline CG107: Hypertension in Pregnancy: The management of hypertensive disorders during pregnancy. National Institute for Health and Clinical Excellence. 2010 https:\/\/www.nice.org.uk\/guidance\/cg107 (accessed 5 Sep 2016)."},{"key":"2025120601051168000_8.7.e022056.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.01.005"},{"key":"2025120601051168000_8.7.e022056.11","doi-asserted-by":"publisher","DOI":"10.1159\/000335366"},{"key":"2025120601051168000_8.7.e022056.12","doi-asserted-by":"publisher","DOI":"10.1002\/uog.12371"},{"key":"2025120601051168000_8.7.e022056.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.02.001"},{"key":"2025120601051168000_8.7.e022056.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-104"},{"key":"2025120601051168000_8.7.e022056.15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025120601051168000_8.7.e022056.16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/1471-0528.13914","article-title":"Low dose aspirin and pregnancy: how important is aspirin resistance?","volume":"123","author":"Navaratnam","year":"2016","journal-title":"BJOG"},{"key":"2025120601051168000_8.7.e022056.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.08.015"},{"key":"2025120601051168000_8.7.e022056.18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2025120601051168000_8.7.e022056.19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12884-016-1033-6","article-title":"Coverage, compliance, acceptability and feasibility of a program to prevent pre-eclampsia and eclampsia through calcium supplementation for pregnant women: an operations research study in one district of Nepal","volume":"16","author":"Thapa","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025120601051168000_8.7.e022056.20","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980009005862"},{"key":"2025120601051168000_8.7.e022056.21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1017\/S1368980007000924","article-title":"Determinants of compliance with iron supplementation among pregnant women in Senegal","volume":"11","author":"Seck","year":"2008","journal-title":"Public Health Nutr"},{"key":"2025120601051168000_8.7.e022056.22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s40264-015-0302-z","article-title":"Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry","volume":"38","author":"de Jonge","year":"2015","journal-title":"Drug Saf"},{"key":"2025120601051168000_8.7.e022056.23","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"2025120601051168000_8.7.e022056.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60157-4"},{"key":"2025120601051168000_8.7.e022056.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10089.x"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-022056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T09:05:18Z","timestamp":1765011918000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-022056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,7,28]]},"published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1136\/bmjopen-2018-022056"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-022056","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}